Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column

Analytical Biochemistry

Volumn 353, Issue 2, 2006, Pages 284-286

  Zhang, Fuming ^a   Sun, Peilong ^b   Muñoz, Eva ^a   Chi, Lianli ^a   Sakai, Shinobu ^c   Toida, Toshihiko ^c   Zhang, Haifeng ^d   Mousa, Shaker ^d   Linhardt, Robert J ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^c CHIBA UNIVERSITY   (Japan)

^d ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

ANION EXCHANGE; SPIN COLUMN;

CHEMISTRY;

CARBAZOLE DERIVATIVE; CHONDROITIN SULFATE; DISACCHARIDE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PEPTIDOGLYCAN; ULINASTATIN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; DRUG BLOOD LEVEL; DRUG ISOLATION; HUMAN; MOLECULAR WEIGHT; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION;

EID: 33646907392     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.01.040     Document Type: Article

References (14)

1. Casu B., and Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57 (2001) 159-206
2. Linhardt R.J. Heparin: structure and activity. J. Med. Chem. 46 (2003) 2551-2554
3. Linhardt R.J. Heparin: an important drug enters its seventh decade. Chem. Ind. 2 (1991) 45-50
4. Linhardt R.J., and Toida T. Role of glycosaminoglycans in cellular communication. Acc. Chem. Res. 37 (2004) 431-438
5. Munoz E.M., and Linhardt R.J. Heparin binding domains in vascular biology. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1549-1557
6. Fareed J., Hoppensteadt D., Schultz C., Ma Q., Kujawski M.F., Neville B., and Messmore H. Biochemical and pharmacologic heterogeneity in low molecular weight heparins: impact on the therapeutic profile. Curr. Pharm. Des. 10 (2004) 983-999
7. Hoppensteadt D.A., Kahn S., and Fareed J. Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs. Clin. Chem. 43 (1997) 1786-1788
8. Toyoda H., Kinoshita-Toyoda A., and Selleck S. Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo. J. Biol Chem. 275 (2000) 2269-2275
9. Ulpin V., Cusamano M., and Venturelli T. Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma. Biochem. Biophys. Acta 1243 (1995) 49-58
10. Bitter T., and Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 4 (1962) 330-334
11. Edens R.E., Al-Hakim A., Weiler J.M., Rethwisch D.G., Fareed J., and Linhardt R.J. Gradient polyacrylamide gel electrophoresis for determination of the molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J. Pharm. Sci. 81 (1992) 823-827
12. Ha Y.W., Jeon B.T., Moon S.H., Toyoda H., Toida T., Linhardt R.J., and Kim Y.S. Characterization of heparan sulfate from the unossified antler of Cervus elaphus. Carbohydr. Res. 340 (2005) 411-416
13. Kobayashi H., Yagyu T., Inagaki K., Kondo T., Suzuki M., Kanayama N., and Terao T. Bikunin plus paclitaxel markedly reduces tumor burden and ascites in mouse model of ovarian cancer. Int. J. Cancer 110 (2004) 134-139
14. Gu K., Liu J., Pervin A., and Linhardt R.J. Comparison of the activity of two chondroitin AC lyases on dermatan sulfate. Carbohydr. Res. 244 (1993) 369-377